Name: Clinical trial of pemigatinib, atezolizumab, and bevacizumab for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusion or rearrangement
Start: 2025-02-13T16:00:00-05:00
End: 2025-02-13T17:00:00-05:00

DONATE

Connect with a Patient Advocate

DONATE

*please note, all times listed are in Eastern Time (ET)

January 2025
January 2 @ 4:00 pm - 5:00 pm Patient Support Group

Patient Support Group
January 6 @ 4:30 pm - 5:30 pm Bereaved Support Group

Bereaved Support Group
January 8 @ 2:30 pm - 4:00 pm Spanish Patient & Caregiver Support Group

Spanish Patient & Caregiver Support Group
January 8 @ 5:30 pm - 6:30 pm Canadian Advocates Meeting

Canadian Advocates Meeting
January 16 @ 4:00 pm - 5:00 pm Caregiver Support Group

Caregiver Support Group
January 22 @ 4:00 pm - 5:00 pm Canadian Bilingual Support Group

Canadian Bilingual Support Group
January 23 @ 4:00 pm - 5:00 pm

CCF Webinar: Histotripsy as a definitive and adjunct therapy for cholangiocarcinoma tumors – A Paradigm Shift
February 2025
February 1 - February 28

Cholangiocarcinoma Awareness Month
February 3 @ 4:30 pm - 5:30 pm Bereaved Support Group

Bereaved Support Group
February 6 @ 4:00 pm - 5:00 pm Patient Support Group

Patient Support Group
February 8 @ 10:00 am - 12:00 pm

Houston CARE Team Meet & Greet
February 11 @ 2:00 pm - 6:00 pm

New England CARE Team Event
February 12 @ 2:30 pm - 4:00 pm Spanish Patient & Caregiver Support Group

Spanish Patient & Caregiver Support Group
February 12 @ 5:30 pm - 6:30 pm Canadian Advocates Meeting

Canadian Advocates Meeting
February 13 @ 4:00 pm - 5:00 pm

Clinical trial of pemigatinib, atezolizumab, and bevacizumab for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusion or rearrangement

January 2025

February 2025